Secondary Anticoagulation Use in Patients < 21 Years Old following Primary Anticoagulant Treatment for Provoked Venous Thromboembolism: Findings from the Kids-DOTT Trial
1 Department of Pediatrics, University of Alabama at Birmingham Heersink School of Medicine and Children's of Alabama, Birmingham, Alabama.
2 Department of Health Informatics, Data Coordinating Center for Pediatric Multicenter Studies, Johns Hopkins All Children's Institute for Clinical and Translational Research, St. Petersburg, Florida.
3 Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland.
4 Department of Pediatrics, Johns Hopkins All Children's Hospital, St. Petersburg, Florida.
5 Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
6 Department of Pediatrics, Feinberg School of Medicine at Northwestern University, Chicago, Illinois.
7 Division of Hematology, Oncology and Stem Cell Transplant, Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois.
8 Department of Pediatrics, University of California San Diego School of Medicine, La Jolla, California.
9 Department of Pediatrics, Rady Children's Hospital San Diego, San Diego, California.
10 Department of Pediatrics, University of Cincinnati College of Medicine and Cincinnati Children's Hospital, Cincinnati, Ohio.
11 Department of Pediatrics, Cohen Children's Medical Center, Northwell Health, New Hyde Park, New York.
12 Department of Pediatrics, Medical University of Vienna, Vienna, Austria.
13 Department of Pediatrics, Newark Beth Israel Medical Center, Rutgers University, Newark, New Jersey.
14 Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
15 Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland.